Executive Insights for Life Sciences Innovators

In this episode of Executive Insights for Life Sciences Innovators , we speak with Anna Kazanchyan, MD, CEO of Saghmos Therapeutics , about the company’s mission to revolutionize cardiovascular and kidney protection. We explore how their lead drug candidate, ST-62516, is designed to prevent Major Adverse Cardiac and Kidney Events (MACKE) in high-risk patients undergoing PCI. Dr. Kazanchyan discuss...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Charles Swindell, CEO of Glycotest , about the company’s proprietary technology that measures glycoprotein fucosylation for the detection of liver diseases. Charles shares insights on the science behind Glycotest’s platform, the challenges of bringing diagnostic innovation to market, and the future of precision live...

In this episode of Executive Insights for Life Sciences Innovators , we sit down with Rich Shea, CEO of Basking Biosciences , to discuss the company’s pioneering work with RNA aptamer technology for the treatment of acute thrombosis. Rich shares insights on Basking’s scientific journey, the challenges of advancing a novel therapeutic approach, and the opportunities ahead in cardiovascular care. Le...

In this episode of Executive Insights for Life Sciences Innovators , we speak with Dr. Nathan Stasko, CEO of Vast Therapeutics , about the company’s journey with nitric oxide technology in respiratory therapeutics. Dr. Stasko shares the challenges of advancing novel drug delivery approaches, lessons learned in building a biotech startup, and his perspective on innovation in life sciences. Learn mo...